Historique
Article de Périodique
Opioid maintenance treatment - A call for a joint European quality care approach (2016)
Auteur(s) :
BRANDT, L. ;
UNGER, A. ;
MOSER, L. ;
FISCHER, G. ;
JAGSCH, R.
Année
2016
Page(s) :
36-51
Langue(s) :
Anglais
Refs biblio. :
70
Domaine :
Drogues illicites / Illicit drugs
Thésaurus géographique
EUROPE
;
AUTRICHE
;
DANEMARK
;
FRANCE
;
ALLEMAGNE
;
NORVEGE
;
PORTUGAL
;
SUEDE
;
ROYAUME-UNI
Thésaurus mots-clés
TRAITEMENT DE MAINTENANCE
;
QUALITE
;
COMPARAISON
;
OPIACES
;
ENQUETE
;
PROFIL SOCIO-DEMOGRAPHIQUE
;
SUBSTITUTION
;
MOTIVATION
;
OBSERVANCE DU TRAITEMENT
Résumé :
Aims: The aim of this exploratory analysis of European Quality Audit of Opioid Treatment data was to identify areas of improvement for current opioid maintenance treatment (OMT) approaches.
Methods: Factors facilitating treatment entry, retention and refusal were compared between 8 European countries and between OMT patient (OMT-P) and active opioid user (AOU) sample groups. Both groups were divided into those who had never had OMT before (un-experienced OMT-P (n = 573) and AOU (n = 360)) and those who had been maintained at least once prior to this investigation (experienced OMT-P (n = 746) and AOU (n = 377)).
Results: The European comparison showed that motives for starting OMT vary distinctly between countries (p <= 0.001). Transnationally, experienced AOU reported concerns about their ability to follow treatment rules and negative treatment experiences as decisive reasons for staying out of OMT. Greater flexibility, less pressure to reduce their treatment dose and greater treatment structure were ranked significantly higher by experienced compared to un-experienced OMT-P as factors that might facilitate treatment retention (p <= 0.05).
Conclusion: Increasing awareness of potential shortcomings of OMT delivery systems is crucial to optimally match treatment approaches to patient needs and also to reduce the considerable economic burden of addiction to society. (C) 2015 S. Karger AG, Basel
Methods: Factors facilitating treatment entry, retention and refusal were compared between 8 European countries and between OMT patient (OMT-P) and active opioid user (AOU) sample groups. Both groups were divided into those who had never had OMT before (un-experienced OMT-P (n = 573) and AOU (n = 360)) and those who had been maintained at least once prior to this investigation (experienced OMT-P (n = 746) and AOU (n = 377)).
Results: The European comparison showed that motives for starting OMT vary distinctly between countries (p <= 0.001). Transnationally, experienced AOU reported concerns about their ability to follow treatment rules and negative treatment experiences as decisive reasons for staying out of OMT. Greater flexibility, less pressure to reduce their treatment dose and greater treatment structure were ranked significantly higher by experienced compared to un-experienced OMT-P as factors that might facilitate treatment retention (p <= 0.05).
Conclusion: Increasing awareness of potential shortcomings of OMT delivery systems is crucial to optimally match treatment approaches to patient needs and also to reduce the considerable economic burden of addiction to society. (C) 2015 S. Karger AG, Basel
Affiliation :
Center for Public Health, Department of Psychiatry and Psychotherapy and Department of Clinical Pharmacology, Medical University of Vienna and Faculty of Psychology, University of Vienna, Vienna, Austria
Cote :
Abonnement